Company intelligence / Profile preview

Open Circle Partners

Japan

Ownership: Private
Development stage: Other

Overview

Open Circle Partners is a consultancy that supports customers in the development of innovative medicines. Their expertise spans biopharmaceuticals, oligonucleotides, gene therapies, and conventional pharmaceuticals. They provide CMC consultation and network clients with external experts to accelerate drug development programs.

Modalities: BiopharmaceuticalsOligonucleotidesGene therapiesConventional medicines
Industry: Consulting

Partnerships

Strategic cooperation agreement with Luxna Biotech for oligonucleotide therapeutics development and CMC consultation

Beyond the preview

Go deeper on Open Circle Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Open Circle Partners.

Explore the full profile